-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| N882341 | 1448237-05-5 | Naquotinib mesylate, ≥98% Naquotinib mesylate, ≥98% |
C31H46N8O6S | |
| N797433 | 1448232-80-1 | Naquotinib(ASP8273), 10mM in DMSO Naquotinib(ASP8273), 10mM in DMSO |
C30H42N8O3 | |
| N873042 | 1448232-80-1 | Naquotinib(ASP8273), 99% Naquotinib(ASP8273), 99% |
C30H42N8O3 | |
| N883928 | 121679-13-8 | Naratriptan, 98% Naratriptan, 98% |
C17H25N3O2S | |
| N884124 | 1190021-64-7 | Naratriptan D3 Hydrochloride, 98% Naratriptan D3 Hydrochloride, 98% |
C17H23D3ClN3O2S | |
| N873480 | 604-80-8 | Narcissoside, 97% Narcissoside, 97% |
C28H32O16 | |
| N793168 | 604-80-8 | Narcissoside, 10mM in DMSO Narcissoside, 10mM in DMSO |
C28H32O16 | |
| N873311 | 128-62-1 | Narcotine, ≥97% Narcotine, ≥97% |
C22H23NO7 | |
| N883847 | 122306-11-0 | Naspm, ≥96% Naspm, ≥96% |
C22H34N4O | |
| N884754 | 1049731-36-3 | Naspm trihydrochloride, ≥98% Naspm trihydrochloride, ≥98% |
C22H37Cl3N4O | |
| N880575 | 209219-38-5 | Nastorazepide, ≥99% Nastorazepide, ≥99% |
C29H36N4O5 | |
| N879085 | 419547-11-8 | NAV-2729 , 98% NAV-2729 , 98% |
C25H17ClN4O3 | |
| N883032 | 1355631-24-1 | Nav1.7 inhibitor , ≥99% Nav1.7 inhibitor , ≥99% |
C15H11Cl3FNO4S | |
| N883205 | 1332295-35-8 | Nav1.7-IN-2 , ≥99% Nav1.7-IN-2 , ≥99% |
C22H22FN5O2 | |
| N878933 | 473727-83-2 | Navarixin, ≥98% Navarixin, ≥98% |
C21H23N3O5 | |
| N797619 | 473727-83-2 | Navarixin, 10mM in DMSO Navarixin, 10mM in DMSO |
C21H23N3O5 | |
| N797692 | 1402837-78-8 | Navoximod, 10mM in DMSO Navoximod, 10mM in DMSO |
C18H21FN2O2 | |
| N882680 | 1402837-78-8 | Navoximod, ≥99% Navoximod, ≥99% |
C18H21FN2O2 | |
| N873043 | 1508250-71-2 | Nazartinib (EGF816, NVS-816), 99% Nazartinib (EGF816, NVS-816), 99% |
C26H31ClN6O2 | |
| N795025 | 1508250-71-2 | Nazartinib (EGF816, NVS-816), 10mM in DMSO Nazartinib (EGF816, NVS-816), 10mM in DMSO |
C26H31ClN6O2 |
